 OncLive | Making Time for Innovation: Myeloma Expert Sets Brisk Pace of Discovery OncLive In both diseases, he has conducted studies that have helped identify patients whose prognoses are either better or worse than average, based on biomarkers or response to stem cell transplant. Specifically, the doctor and his colleagues came up with a ... |
